PPAR Ligands for Metabolic Disorders
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1649-1661
Author(s):
Garret J. Etgen and Nathan Mantlo
Symptomatic Treatment of Chronic Neuropathic Pain with Gabapentin Clinical Practice and Research Prospective
Journal:
Current Neuropharmacology
Volume:
1
Page:
199-202
Author(s):
Misha-Miroslav Backonja
Anticonvulsant Action and Long-term Effects of Gabapentin
Journal:
Current Neuropharmacology
Volume:
1
Page:
203-208
Author(s):
M. R. Cilio
Cellular Actions of Gabapentin and Related Compounds on Cultured Sensory Neurones
Journal:
Current Neuropharmacology
Volume:
1
Page:
219-235
Author(s):
Roderick H. Scott, Duncan J. Martin and David McClelland
Gabapentin-Mediated Effects on Voltage- and Ligand-Gated Currents
Journal:
Current Neuropharmacology
Volume:
1
Page:
237-244
Author(s):
Alessandro Stefani and Atticus Henry Hainsworth
A Possible Target of Antioxidative Therapy for Diabetic Vascular Complications-Vascular NAD(P)H Oxidase
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1759-1764
Author(s):
T. Inoguchi, H. Tsubouchi, T. Etoh, M. Kakimoto, T. Sonta, H. Utsumi, H. Sumimoto, H. Y. Yu, N. Sonoda, M. Inuo, N. Sato, N. Sekiguchi, K. Kobayashi and H. Nawata
Stages of HIV Replication and Targets for Therapeutic Intervention
Journal:
Current Topics in Medicinal Chemistry
Volume:
3
Page:
1447-1457
Author(s):
Jozsef Tozser
Novel Cardiovascular Risk Factors and Macrovascular and Microvascular Complications of Diabetes
Journal:
Current Drug Targets
Volume:
4
Page:
477-486
Author(s):
P. Theuma and V. A. Fonseca
Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1665-1678
Author(s):
Robert J. MacFadyen, Gregory Y.H. Lip and Russell Davis
Hypertension and Angiogenesis
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1733-1744
Author(s):
F. N. Kiefer, S. Neysari, R. Humar, W. Li, V. C. Munk and E. J. Battegay